BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25131586)

  • 21. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
    Bobori C; Theocharopoulou G; Vlamos P
    Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Nucleolus as a Proteostasis Regulator.
    Amer-Sarsour F; Ashkenazi A
    Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular chaperones and neuronal proteostasis.
    Smith HL; Li W; Cheetham ME
    Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of molecular chaperones in human misfolding diseases.
    Broadley SA; Hartl FU
    FEBS Lett; 2009 Aug; 583(16):2647-53. PubMed ID: 19393652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein folding and misfolding in the neurodegenerative disorders: a review.
    Bolshette NB; Thakur KK; Bidkar AP; Trandafir C; Kumar P; Gogoi R
    Rev Neurol (Paris); 2014 Mar; 170(3):151-61. PubMed ID: 24613386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the role of molecular chaperones in protein homeostasis.
    Tiroli-Cepeda AO; Ramos CH
    Protein Pept Lett; 2011 Feb; 18(2):101-9. PubMed ID: 21121892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ; Wacker JL
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chaperone networks: tipping the balance in protein folding diseases.
    Voisine C; Pedersen JS; Morimoto RI
    Neurobiol Dis; 2010 Oct; 40(1):12-20. PubMed ID: 20472062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
    Sinnige T; Yu A; Morimoto RI
    Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4D imaging of protein aggregation in live cells.
    Spokoini R; Shamir M; Keness A; Kaganovich D
    J Vis Exp; 2013 Apr; (74):. PubMed ID: 23608881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
    Karatas E; Bouchecareilh M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ER chaperone-metal interactions: links to protein folding disorders.
    Tiffany-Castiglioni E; Qian Y
    Neurotoxicology; 2012 Jun; 33(3):545-57. PubMed ID: 22370090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cumulative impact of chaperone-mediated folding on genome evolution.
    Bogumil D; Dagan T
    Biochemistry; 2012 Dec; 51(50):9941-53. PubMed ID: 23167595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular chaperones and proteostasis.
    Wyatt AR; Yerbury JJ; Ecroyd H; Wilson MR
    Annu Rev Biochem; 2013; 82():295-322. PubMed ID: 23350744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chaperones in control of protein disaggregation.
    Liberek K; Lewandowska A; Zietkiewicz S
    EMBO J; 2008 Jan; 27(2):328-35. PubMed ID: 18216875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
    Bose S; Cho J
    Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.